INOVIQ has partnered with Promega Corporation to generate commercial exosome isolation and nucleic acid extraction solutions.
The partnership aims to commercialize INOVIQ’s EXO-NET, a tool for capturing exosomes, with the help of Promega’s resources in nucleic acid purification. EXO-NET is an immunoaffinity magnetic bead-based isolation system designed for capturing exosomes from various human biofluids.
Promega Corporation is a biotechnology and life sciences research company. It offers various products, including tools and technologies that support scientific work in cell biology, DNA, RNA, and protein analysis, drug development, and molecular diagnostics fields. Promega’s proprietary technologies include the HaloTa Protein Labeling and Analysis, HiBiT Protein Tagging, and NanoLuc Luciferase, used in research and industrial applications.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.